- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02492451
Endometrial Injury Versus Luteal Phase Support in Intrauterine Insemination Cycles
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
Group 1: Endometrial biopsy is performed on days 21-24 of the spontaneous menstrual cycle proceeding the intrauterine insemination (IUI) treatment cycle. Two small biopsies are obtained from anterior and posterior walls of the uterus.
Group 2: Vaginal progesterone gel is administered for luteal phase support from second day after insemination until pregnancy testing and is continued in the presence of pregnancy until the 12 weeks of pregnancy.
Goup 3: Patients are undergone intrauterine insemination (IUI) cycles stimulated with gonadotropin without any intervention.
The effect of endometrial injury and luteal phase progesterone support on the pregnancy rate in patients intrauterine insemination (IUI) cycles stimulated with gonadotropin will be compared in terms of biochemical pregnancy rate, clinical pregnancy rate and ongoing pregnancy rate.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
-
İstanbul, Kalkun
- Selcuk Selcuk
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Patients are undergone intrauterine insemination with gonadotropin stimulation
- Bilateral patent fallopian tubes revealed by hysterosalpingography or laparoscopy
- After semen preparation for intrauterine insemination, total progressive sperm count > 5 million
Exclusion Criteria:
- endocrin or metabolic disorders,
- uterine factor,
- pelvic inflammatory disease,
- women with basal follicle-stimulating hormone (FSH) level >15 IU/mL,
- body mass index (BMI) ≥ 35 kg/m2,
- age ≥ 40 and < 18 years,
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Aktiv komparator: Endometrial Injury
Endometrial injury in luteal phase of preceding IUI cycle
|
Endometrial injury in luteal phase of preceding cycle by pipelle canula
|
Aktiv komparator: Luteal Phase Support
Luteal phase support with progesterone (Crinone® %8 vaginal progesterone gel) in IUI cycle Vaginal progesterone gel is administered from second day after insemination until pregnancy testing and is continued in the presence of pregnancy until the 12 weeks of pregnancy.
|
Luteal phase support with progesterone (Crinone® %8 vaginal progesterone gel) in IUI cycle Vaginal progesterone gel is administered from second day after insemination until pregnancy testing and is continued in the presence of pregnancy until the 12 weeks of pregnancy.
|
Ingen indgriben: Control group
Only IUI
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Pregnancy Rate
Tidsramme: 12 weeks
|
ongoing pregnancy rates
|
12 weeks
|
Samarbejdspartnere og efterforskere
Publikationer og nyttige links
Generelle publikationer
- Bui BN, Lensen SF, Gibreel A, Martins WP, Torrance H, Broekmans FJ. Endometrial injury for pregnancy following sexual intercourse or intrauterine insemination. Cochrane Database Syst Rev. 2022 Oct 24;10(10):CD011424. doi: 10.1002/14651858.CD011424.pub4.
- Bui BN, Lensen SF, Gibreel A, Martins WP, Torrance H, Broekmans FJ. Endometrial injury for pregnancy following sexual intercourse or intrauterine insemination. Cochrane Database Syst Rev. 2021 Mar 18;3(3):CD011424. doi: 10.1002/14651858.CD011424.pub3.
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- zeynepkamil
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Graviditet
-
King's College Hospital NHS TrustEuropean Association for the Study of the LiverRekrutteringCirrhose, lever | HELLP syndrom | Intrahepatisk kolestase af graviditet | Graviditetssygdom | AFLP - Acute Fatty Lever of PregnancyDet Forenede Kongerige
Kliniske forsøg med Endometrial Injury
-
Mansoura UniversityUkendtInfertilitet | Polycystisk ovariesyndromEgypten
-
Cairo UniversityAfsluttet
-
Birmingham Women's NHS Foundation TrustUkendt
-
Simon Fraser UniversityRekrutteringSynkope, Vasovagal | Blod, injektion, fobi af type skadeCanada
-
Weill Medical College of Cornell UniversityAfsluttet
-
The First Affiliated Hospital of Zhengzhou UniversityUkendt
-
Benha UniversityUkendt
-
Minerva Surgical, Inc.AfsluttetMenorragi på grund af godartede årsagerMexico
-
Minerva Surgical, Inc.AfsluttetMenorragi på grund af godartede årsagerCanada
-
University of California, San FranciscoNational Center for Advancing Translational Sciences (NCATS)Ikke rekrutterer endnuTraumeskade | Overlevelse | Traumatisk skadeForenede Stater